$64.74+14.04% · 3M
Moving avg
1W+0.03%
1M+10.25%
3M+13.58%
6M+6.59%
YTD+21.10%
1Y+35.41%
3Y+5.06%
5Y-5.74%
52-week range
$42.52100% of range$62.89
Company health
Value3/6
Growth5/6
Profitability5/6
Health2/6
Dividend4/6
Bull vs bear
Strengths
- High return on equity (3905%)
- Revenue compounding 11% a year
- Pays a 4.0% dividend
Risks
- Highly leveraged (debt is 2.6x equity)
Key statistics
Valuation
Market cap
$132.25B
Enterprise value
$161.68B
P/E ratio (TTM)
17.44x
P/S ratio (TTM)
2.62x
EV/EBITDA
11.76x
Per share & returns
EPS (TTM)
$3.56
Dividend yield
4.04%
Beta (1Y)
0.23
30-day change
+10.25%
Trading
Volume (24h)
3.06M
Previous close
$63.70
Shares outstanding
2.04B
About Bristol-Myers Squibb Company
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Symbol
BMY
Bristol-Myers Squibb Company is a large-cap healthcare company in the Drug Manufacturers - General industry. Its shares are listed on NYSE (United States) and trade under the ticker BMY.
Frequently asked questions
What is Bristol-Myers Squibb Company's market cap?
Bristol-Myers Squibb Company (BMY) has a market capitalization of $132.25B.
What is Bristol-Myers Squibb Company's P/E ratio?
Bristol-Myers Squibb Company trades at a price-to-earnings (P/E) ratio of 17.44.
What exchange does BMY trade on?
BMY trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,215.75-0.37%
$1.14T cap
Johnson & JohnsonJNJ
$261.27+0.16%
$629.63B cap
AbbVie Inc.ABBV
$250.22+0.59%
$442.09B cap
UnitedHealth Group IncorporatedUNH
$402.23-0.83%
$365.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.76+1.38%
$332.83B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap